Navigation Links
Pharmasset Reports Fiscal Year End 2008 Financial Results
Date:12/11/2008

rst calendar half of 2009.

PSI-7851

During 2008, Pharmasset nominated PSI-7851 as its lead, second generation nucleotide candidate for HCV. Preclinical data indicate that PSI-7851 could be up to 20 times more potent than R7128, raising the prospect that the drug might be used in fixed dose combinations in the future. The company plans to file an IND for PSI-7851 in the first calendar quarter of 2009.

"During 2008, Pharmasset made significant progress both in the clinic and on the corporate front," said Schaefer Price, Pharmasset's President and CEO. "We remain focused on maintaining this momentum and building a pipeline of differentiated antiviral candidates. Through our collaboration with Roche, the leader in HCV market, we plan to rapidly progress R7128 through phase 2 studies. The partnership is also exploring the paradigm changing model of an all oral (interferon sparing) regimen for HCV, which we believe would be the future of treatment. These efforts provide the groundwork for our next generation of nucleoside and nucleotide inhibitors, such as PSI-7851, that hold the potential for us to explore fixed dosed combinations."

Financial Results

For the fiscal year ended September 30, 2008 Pharmasset reported revenues of $1.9 million, compared with revenues of $22.0 million for the fiscal year 2007. The receipt of milestones totaling $20 million from Roche led to higher reported revenues in the fiscal year 2007.

Total costs and expenses for the fiscal year ended September 30, 2008 were $56.3 million as compared to $29.5 million for the same period in 2007. The increased operating expenses for fiscal year 2008 were primarily the result of an increase in Phase 3 registration clinical trial expenses for clevudine for the treatment of chronic HBV infection, as well as increased drug discovery activities and the administrative expenses of a public company.


'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
2. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
3. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
4. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
5. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
6. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
7. Pharmasset Receives Notice of Allowance
8. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
11. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research and ... addition of the "Inferior Vena Cava (IVC) Filters ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... sector is projected to reach US$435 million by 2016. ... nearly 39% (2015) of the global value while ...
(Date:12/15/2014)... Norway , December 15, 2014 ... innovative drugs for aggressive drug resistant cancers, today announces ... in a private placing from new and existing investors. ... financing to support the development of its pipeline of ... program for its lead drug candidate, BGB324, a first-in-class ...
(Date:12/15/2014)... Dec. 15, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... been added to the NASDAQ Biotechnology Index (NBI). ... become effective upon market open on December 22, ... designed to track the performance of a set ... biotechnology or pharmaceutical according to the Industry Classification ...
Breaking Medicine Technology:Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 4BerGenBio Completes NOK90 Million Fundraising 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4
... Jan. 18, 2011 Rochester Medical Corporation (Nasdaq: ... markets close on Tuesday, January 25, 2011.  The Company ... its earnings report.  The Company also plans to discuss ... 12, 2011.  The call will begin at 3:30 p.m. ...
... 18, 2011 Fenwal, Inc. of Lake Zurich, Illinois, ... signed an agreement under which Fenwal will co-market and ... plasma centers and hospitals in the United States and ... Genesis™ blood collection mixers and monitors, RapidSeal II™ tube ...
Cached Medicine Technology:Rochester Medical Announces First Quarter 2011 Earnings Conference Call Tuesday, January 25, 2011 2Fenwal, GenesisBPS Enter Agreement for Blood-Specialty Products 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... plan of enforcing a ban on smoking in enclosed public ... such other public places will come under the purview of ... private homes. ,All pubs and restaurants in England ... in their location from July 1st, 2007. According to Health ...
... Guanfacine, a medication commonly prescribed to alleviate symptoms of post-traumatic ... to a study// led by researchers at the San Francisco ... all, and there were several adverse side effects,” says lead ... program at SFVAMC. “People with symptoms of PTSD should probably ...
... an eating disorder - monitoring meals, friends and activities - ... researchers at the Stanford University School of Medicine// and Lucile ... two key areas: Internet use among adolescents with the condition, ... ,One study, to be published in the December issue of ...
... treated mainly elderly patients for health problems such as ... patients who have the same ailments. ,A ... focuses on the increasing prevalence of metabolic syndrome, a ... high blood pressure and abnormal levels of glucose (sugar) ...
... undertake a long-term weight training program produce more ... physiologists //to understand why weight training improves muscle ... study published in the December issue of the ... different forms of growth hormone, used different testing ...
... neo-natal care find recordings of consultations with their consultants ... requiring care in neo-natal intensive care units (NICU) often ... in Australia set out to assess the usefulness of ... consultants. Two hundred mothers with babies in NICU were ...
Cached Medicine News:Health News:Common PTSD Drug is No More Effective Than Placebo 2Health News:Study Focus on the Need for Vigilance in Two Key Areas Among Adolescents 2Health News:Study Focus on the Need for Vigilance in Two Key Areas Among Adolescents 3Health News:Treating Obesity Vital for Public Health, Physicians Say 2Health News:Varying Weight Training Intensity Ups Growth Hormone in Women 2
... Advanced Technologies, The UroMax Ultra ia ... of high pressure and low profile., ... yields a remarkably strong material that ... balloon materials., Non-Compliant Balloons, A compliant ...
... Fr Straight Channel; 33 or 42 cm ... Operating Ureteroscopes offer a small distal diameter ... to the ureter for diagnosis and treatment. ... ideal for large operating instruments, mechanical (Lithoclast) ...
... Small 6.9 Fr Diameter with Two ... ,MICRO-6L Long Semi-Rigid Ureteroscope, with a longer ... ureteroscope with two large working channels for ... allow you to basket a stone and ...
... The ACMI USA Series DUR-8 Durable Flexible ... the entire intrarenal collecting system with little ... superior secondary deflection allow complete intrarenal access, ... facilitates access to the proximal ureter and ...
Medicine Products: